Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.24% | 19.84% | 22.01% | 22.34% | 26.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.24% | 19.84% | 22.01% | 22.34% | 26.26% |
| Cost of Revenue | 23.36% | 23.76% | 21.56% | 18.54% | 23.58% |
| Gross Profit | 16.45% | 18.48% | 22.16% | 23.72% | 27.22% |
| SG&A Expenses | 7.28% | 7.90% | 7.96% | 8.10% | 11.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.56% | 9.12% | 8.33% | 7.88% | 11.29% |
| Operating Income | 3.95% | 3.89% | 6.83% | 7.08% | 3.49% |
| Income Before Tax | 1.55% | 2.50% | 7.26% | 7.04% | 4.52% |
| Income Tax Expenses | -6.07% | -29.07% | -12.43% | 24.78% | 13.14% |
| Earnings from Continuing Operations | 1.60% | 2.79% | 7.31% | 6.75% | 4.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.60% | 2.79% | 7.31% | 6.75% | 4.37% |
| EBIT | 3.95% | 3.89% | 6.83% | 7.08% | 3.49% |
| EBITDA | 3.61% | 3.72% | 6.95% | 7.05% | 3.44% |
| EPS Basic | 4.81% | 5.78% | 10.02% | 9.36% | 6.90% |
| Normalized Basic EPS | 4.77% | 5.49% | 9.98% | 9.65% | 7.06% |
| EPS Diluted | 4.81% | 5.78% | 10.02% | 9.36% | 6.90% |
| Normalized Diluted EPS | 4.77% | 5.49% | 9.98% | 9.65% | 7.06% |
| Average Basic Shares Outstanding | 3.35% | 3.14% | 3.00% | 2.88% | 2.74% |
| Average Diluted Shares Outstanding | 3.35% | 3.14% | 3.00% | 2.88% | 2.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |